The share price of Biogen Inc. (NASDAQ:BIIB) tumbled as much as 8 percent, to $395, Friday after sales of the …
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing …
Biogen Inc. (NASDAQ: BIIB) discovers, develops and delivers to patients …
Novartis’s Gilenya competes with Sanofi’s (SNY) Aubagio, Biogen’s (BIIB) Fampyra, Tecfidera ... Notably, the Vanguard Total International Stock ETF (VXUS) has …
A 2.78% percent loss this year for shares of Biogen Inc. (BIIB ) was accompanied by overwhelming institutional selling, thus leading this stock to underperform. But now it looks like the tide may have shifted in favor of institutional buying. …
BIIB). Highline Capital Management had $76.3 million invested in the company at the end of the quarter. Ken Griffin’s Citadel Investment Group also made a $71.7 million investment in the stock during the quarter. The other funds with …
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here. Biogen (NASDAQ: BIIB) announced that its Board of Directors authorized a program to repurchase up to $5 billion of the …
Rating reiterations for Monday from Briefing.com: Company Symbol Brokerage Firm Reiterations Applied Materials AMAT Bear Stearns Outperform ArthroCare ARTC Needham & Co Buy Ashford Hospitality Trust AHT RBC Capital Markets …
Yesterday’s rumored M&A interest in Biogen Inc (NASDAQ:BIIB) spiked the stock 10% in a single day. Now that the euphoria has died down, let’s examine what a realistic takeover number might be. With both Merck and Allergan …
Biogen Inc. (BIIB) announced Thursday morning that data shows that earlier ... Biogen gapped open higher Thursday morning and has continued to rise in early trade. The stock is now up 10.99 at $325.91. Biogen has climbed to a 3 …